MedTrace Logo

Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome

NCT02788071 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2017-08-02

No results posted yet for this study

Summary

The purpose of this study is to investigate if fecal microbiota transplantation (FMT) will result in improvement in clinical outcome in patients with irritable bowel syndrome (IBS).

Conditions

  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

FMT capsules

25 capsules per day for 12 days

DIETARY_SUPPLEMENT

FMT placebo

25 capsules per day for 12 days

Sponsors & Collaborators

  • Hvidovre University Hospital

    collaborator OTHER

  • University of Aarhus

    collaborator OTHER

  • Aleris-Hamlet Hospitaler København

    lead OTHER

Principal Investigators

  • Alice Højer Christensen, MD, PhD · Aleris-Hamlet Hospitaler København

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02788071 on ClinicalTrials.gov